Fulcrum Therapeutics's total assets for Q1 2026 were $346.77M, a decrease of -5.33% from the previous quarter. FULC total liabilities were $13.47M for the fiscal quarter, a -22.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.